Legal & General Ventures, the private equity arm of the eponymous financial services group, has bought healthcare products manufacturer and distributor Verna for £60 million.
Plethora Solutions, developer of products treating a variety of urological diseases, has floated on AIM, raising £10 million in a placing advised by Collins Stewart.
Rolf Stahel, the well-regarded former chief executive of Shire Pharmaceuticals, has agreed to become non-executive chairman of Oxford-based PowderMed, a specialist in developing immunotherapeutics.
